Hepatitis C virus core protein enhances NF-κB signal pathway triggering by lymphotoxin-β receptor ligand and tumor necrosis factor alpha

Journal of Virology

Volumn 73, Issue 2, 1999, Pages 1672-1681

  You, Li Ru ^a   Chen, Chun Ming ^a   Lee, Yan Hwa Wu ^a  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CORE PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR PROTEIN; LYMPHOTOXIN; PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; DNA BINDING; ELECTROPHORETIC MOBILITY; HELA CELL; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

EID: 0032906988     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.2.1672-1681.1999     Document Type: Article

References (113)

1. Aggarwal, B. B., and K. Natarajan. 1996. Tumor necrosis factors: developments during the last decade. Eur. Cytokine Netw. 7:93-124.
2. Arizawa, S., I. Scheffrahn, G. Mosialos, H. Brand, J. Duyster, K. Kaye. J. Harada, B. Dougall, G. Hubinger, E. Kieff, F. Herrmann, A. Leutz, and H. J. Gruss. 1997. Tumor necrosis factor receptor-associated factor (TRAF) 5 and TRAF2 are involved in CD30-mediated NF-κB activation. J. Biol. Chem. 272:2042-2045.
3. Baens, M., M. Chaffanet, J. J. Cassiman, H. Den Berghe, and P. Mannen. 1993. Construction and evaluation of a HNcDNA library of human 12p transcribed sequences derived from a somatic cell hybrid. Genomics 16: 214-218.
4. Baeuerle, P. A., and D. Baltimore. 1996. NF-κB: ten years after. Cell 87:13-20.
5. Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12:141-179.
6. Baichwal, V. R., and P. A. Baeuerle. 1997. Apoptosis: activate NF-κB or die? Curr. Biol. 7:R94-R96.
7. Baker, S. J., and E. P. Reddy. 1996. Transducers of life and death: TNF receptor superfamily and associated protein. Oncogene 12:1-9.
8. Baldwin, J. A. S. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649-681.
9. Barba, G., F. Harper, T. Harada, M. Kohara, S. Goulinet, Y. Matsuura, G. Eder, Z. Schaff, M. J. Chapman, T. Miyamura, and C. Brechot. 1997. Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc. Natl. Acad. Sci. USA 94:1200-1205.
10. Bartenschlager, R., L. Ahlborn-Laake, J. Mous, and H. Jacobsen. 1993. Nonstructural protein 3 of the hepatitis C virus encodes a scrine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions. J. Virol. 67:3835-3844.
11. Battegay, M., J. Fikes, A. M. DiBisceglie, P. A. Wentworth, A. Sette, E. Cells, W.-M. Ching, A. Grakoui, C. M. Rice, K. Kurokohchi, J. A. Berzofsky, J. H. Hoofnagle, S. M. Feinstone, and T. Akatsuka. 1995. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. J. Virol. 69:2462-2470.
12. Beg, A. A., and D. Baltimore. 1996. An essential role for NF-κB in preventing TNF-α-induccd cell death. Science 274:782-784.
13. Béraud, C., S.-C. Sun, P. Gauchi, D. W. Ballard, and W. C. Greene. 1994. Human T-cell leukemia virus type I Tax associates with and is negatively regulated by the NF-κB2 p100 gene product: implications for viral latency. Mol. Cell. Biol. 14:1374-1382.
14. Berberich, I., G. Shu, F. Siebelt, J. R. Woodgelt, J. M. Kyriakis, and E. A. Clark. 1996. Cross-linking CD40 on B cells preferentially induces stress-activated protein kinases rather than mitogen-activatcd protein kinases. EMBO J. 15:92-101.
15. Beutler, B., and C. van Huffel. 1994. Unraveling functions in the TNF ligand and receptor families. Science 264:667-668.
16. Bex, F., A. McDowail, A. Burny, and R. Gaynor. 1997. The human T-cell leukemia virus type 1 transactivator protein Tax colocalizes in unique nuclear structures with NF-κB proteins. J. Virol. 71:3484-3497.
17. Browning, J. L., K. Miatkowski, D. A. Griffiths, P. R. Bourdon, C. Hession, C. M. Ambrose, and W. Meier. 1996. Preparation and characterization of soluble recombinant heterotrimeric complexes of human lymphotoxins α and β. J. Biol. Chem. 271:8616-8626.
18. Browning, J. L., K. Miatkowski, I. Sizing. D. Griffiths, M. Zafari, C. D. Benjamin, W. Meier, and F. Mackay. 1996. Signaling through the lymphotoxin β receptor induces the death of some adenocarcinoma tumor lines. J. Exp. Med. 183:867-878.
19. Bruix. J., J. M. Barrera, X. Calvel, G. Ercilla, J. Costa, J. M. Sanchez-Tapias, M. Ventura, M. Vall, M. Bruguera, C. Bru, R. Castillo, and J. Rodes. 1989. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet ii:1004-1006.
20. Cerny, A., J. G. McHutchison, C. Pasquinelli, M. E. Brown, M. A. Brothers, B. Grabscheid, P. Fowler, M. Houghton, and F. V. Chisari. 1995. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J. Clin. Investig. 95:521-530.
21. Chen, C.-M., L.-R. You, L.-H. Hwang, and Y.-H. W. Lee. 1997. Direct interaction of hepatitis C virus core protein with the cellular lymphotoxin-β receptor modulates the signal pathway of the lymphotoxin-β receptor. J. Virol. 71:9417-9426.
22. Chen, C.-M., Y.-H. W. Lee, H. Wajant, and M. Grell. Identification of the signal transducing region of the lymphotoxin-β receptor (LT-βR) coupling to TRAF2-depcndent activation of NF-βB and c-Jun N-terminal kinase. Submitted for publication.
23. Cheshire, J. L., and J. A. S. Baldwin. 1997. Synergistic activation of NF-βB by tumor necrosis factor alpha and gamma interferon via enhanced IκBα degradation and de novo IκBβ degradation. Mol. Cell. Biol. 17:6746-6754.
24. Chirillo, P., M. Falco, P. L. Puri, M. Artini, C. Balsano, M. Levrero, and G. Natoli. 1996. Hepatitis B virus pX activates NF-κB-dependent transcription through a Raf-independent pathway. J. Virol. 70:641-646.
25. Choo, Q.-L., G. Kuo, A. J. Weiner, L. R. Overby, D. W. Bradley, and M. Houghton. 1989. Isolation of a cDNA clone derived from a blood-borne mm-A. non-B viral hepatitis genome. Science 244:359-362.
26. Chu, Z. L., J. A. DiDonato, J. Hawiger, D. W. Ballard. 1998. The Tax oncoprntein of human T-cell leukemia virus type 1 associates with and persistently activates IκB kinases containing IKKα and IKKβ. J. Biol. Chem. 273:115891-15894.
27. Coso, O. A., M. Chiarello, J.-C. Yu, H. Teramoto, P. Crespo, N. Xu, T. Miki, and J. S. Gutkind. 1995. The small GTP-binding proteins racl and cdc42 regulate the activity of the JNK/SAPK pathway. Cell 81:1137-1146.
28. Crowe, P. D., T. L. VanArsdale, B. N. Walter, C. F. Ware, C. Hession, B. Ehrenfels, J. L. Browning, W. S. Din, R. C. Goodwin, and C. A. Smith. 1994. A lymphotoxin-β-specific receptor. Science 264:707-710.
29. Derijard, B., M. Hibi, I.-H. Wu, T. Barrett, B. Su, T. Deng, M. Karin, and R. J. Davis. 1994. JNK1: a protein kinase stimulated hy UV light and Ha-ras that binds and phosphorylates the c-Jun activation domain. Cell 76:1025-1037.
30. Derijard, B., J. Raingeaud, T. Barrett, I.-H. Wu, J. Han, R. J. Ulevitch, and R. J. Davis. 1995. Independent human MAP kinase signal transduction pathways defined by MEK and MKK isoforms. Science 267:682-685.
31. De Togni, P., J. Goellner, N. H. Ruddle, P. R. Streeter, A. Fick, S. Mariathasan, S. C. Smith, R. Carlson, L. P. Shornick, J. Strauss-Schoenberger, J. H. Russell, R. Karr, and D. D. Chaplin. 1994. Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 264: 703-707.
32. DiDonato, J. A., M. Hayakawa, D. M. Rothwarf, E. Zandi, and M. Karin. 1997. A cytokine-responsive IκB kinase that activates the transcription factor NF-κB. Nature 388:548-554.
33. Ettinger, R., J. L. Browning, S. A. Miehie, W. van Ewijk, and H. O. McDevitt. 1996. Disrupted spenic architecture, but normal lymph node development in mice expressing a soluble lymphotoxin-β receptor-IgG1 fusion protein. Proc. Natl. Acad. Sci. USA 93:13102-13107.
34. Force, W. R., T. C. Cheung, and C. F. Ware. 1997 Dominant negative mutants of TRAF3 reveal an important role for the coiled coil domains in cell death signaling by the lymphotoxin-β receptor. J. Biol. Chem. 272: 30835-30840.
35. Good, L., and S.-C. Sun. 1996. Persistent activation of NF-κB/Rel by human T-cell leukemia virus type 1 Tax involves degradation of 1κBβ. J. Virol. 70:2730-2735.
36. Gooding, L. R. 1992. Virus proteins that counteract host immune defenses. Cell 71:5-7.
37. Grakoui, A., D. W. McCourt, C. Wychowski, S. M. Feinstone, and C. M. Rice. 1993. Characterization of the hepatitis C virus-encoded serine prolcinase: determination of proteinase-dependent polyprotein cleavage sites. J. Virol. 67:2832-2843.
38. Gupta, S., D. Campbell, B. Derijard, and R. J. Davis. 1995. Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 267:389-393.
39. Heller, R. A., and M. Kronk. 1994. Tumor necrosis factor-mediated signaling pathways. J. Cell Biol. 126:5-9.
40. Herrero, J. A., P. Mathew, and C. V. Paya. 1995. LMP-1 activates NF-κB by targeting the inhibitory molecule IκBα. J. Virol. 69:2168-2174.
41. Hibi, M., A. Lin, T. Smeal, A. Minden, and M. Karin. 1993. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 7:2135-2148.
42. Hirai, H., J. Fujisawa, T. Suzuki, K. Ueda, M. Muramatsu, A. Tsuboi, N. Arai, and M. Yoshida. 1992. Transcriptional activator Tax of HTLV-1 binds to the NF-κB precursor p105. Oncogene 7:1737-1742.
43. Hirai, H., J. Fujisawa, T. Suzuki, J.-I. Fujisawa, J.-I. Inoue, and M. Yoshida. 1994. Tax protein of human T-cell leukemia virus type I binds to the ankyrin motifs of inhibitory factor κB and induces nuclear translocation of transcription factor NF-κB proteins for transcriptional activation. Proc. Natl. Acad. Sci. USA 91:3584-3588.
44. Hirano, M., S. Osada, T. Aoki, S. Hirai, M. Hosaka, J. Inoue, and S. Ohno. 1996. MEK kinase is involved in tumor necrosis factor α-induced NF-κB activation and degradation of IκB-α. J. Biol. Chem. 271:13234-13238.
45. Hsu, H., H.-B. Shu, M.-G. Pan, and D. Goeddel. 1996. TRADD-TRAF2 and TRADD-FADD interaction define two distinct TNF receptor 1 signal transduction pathways. Cell 84:299-308.
46. Hsu, H., J. Xiong, and D. Goeddel. 1995. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell 81:495-504.
47. Izumi, K, M., and E. U. Kieff. 1997. The Epstein-Barr virus oncogene product latent membrane protein I engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-κB. Proc. Natl. Acad. Sci. USA 94:12592-12597.
48. Johnson, D. R., I. Douglas, A. Jahnke, S. Ghosh, and J. S. Pober. 1996 A sustained reduction in IκB-β may contribute to persistent NF-κB activation in human endotheliul cells. J. Biol. Chem. 271:16317-16322.
49. Karin, M. 1995. The regulation of AP-I activity by mitogen-activatcd protein kinases. J. Biol. Chem. 270:16483-16486.
50. Koziel, M. J., U. Dudley, N. Afdhal, Q. L. Choo, M. Houghton. R. Ralston, and B. D. Walker. 1993. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J. Virol. 67:7522-7532.
51. Kuo, G., Q.-L. Choo, H. J. Aller, G. L Gitnick, A. G. Redeker, R. H. Purcell, T. Miyamura, L. Dienstag, M. J. Alter, C. E. Stevens, G. E. Tegtmeier. F. Bonino, M. Colombo, W.-S. Lee, C. Kuo, K. Berger, J. R. Sinister, L. R. Overby, D. W. Bradely, and M. Houghton. 1989. An assay for circulating antibodies to a major etiologic virus of human non-A. non-B hepatitis. Science 244:362-364.
52. Kyriakis, J. M., and Avruch, J. 1996. Sounding the alarm: protein kinase cascades activated by stress and inflammation. J. Biol. Chem. 271:24313-24316.
53. Kyriakis, J. M., P. Banerjee, E. Nikolaki, T. Dai, E. A. Ruble, M. F. Ahmad, J. Avruch, and J. R. Woodgett. 1994. The stress-activated protein kinase subfamily of c-Jun kinases. Nature 369:156-160.
54. Lacoste. J., L. Petropoulos, N. Pepin, and J. Hiscott. 1995. Constitutive phosphorylation and turn over of IκBα in human T-cell leukemia virus type 1-infecled and Tax-expressing T cells. J. Virol. 69:564-569.
55. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
56. Lange-Carter, C. A., C. M. Pleiman, A. M. Gardner, K. J. Blumer, and G. L. Johnson. 1993. A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf. Science 260:315-319.
57. LeBail, O., R. Schmidt-Ulrich, and A. Israel. 1993 Promoter analysis of the gene encoding the IκBα/MAD3 inhibitor of NF-κB: positive regulation by members of the rel/NF-κB family. EMBO J. 12:5043-5049.
58. Lee, F. S., J. Hagler, Z. J. Chen, and T. Maniatis. 1997. Activation of the IκBα kinase complex by MEKK1, a kinase of the JNK pathway. Cell 88:213-222.
59. Lin, C., B. D. Lindenbach, B. M. Pragai, D. W. McCourt, and C. M. Rice. 1994. Processing in the hepatitis C virus E2-NS2 region: identification of p7 and two distinct E2-specific products with different C termini. J. Virol. 68:5063-5073.
60. Liu, Z.-G., H. Hsu, D. Goeddel, and M. Karin. 1996. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87:565-576.
61. Lo, S.-Y., F. Masiarz, S. B. Hwang, M. M. C. Lai, and J.-H. Ou. 1995. Differential subcellular localization of hepatitis C virus core gene products. Virology 213:455-461.
62. Mackay, F., G. R. Majeau. P. S. Hochman, and J. L. Browning. 1996. Lymphotoxin β receptor triggering induces activation of the nuclear factor κB transcription factor in some cell types. J. Biol. Chem. 271:24934-24938.
63. Mackay, F, G. R. Majeau, P. Lawton, P. S. Hochman, and J. L. Browning. 1997. Lymphotoxin but not tumor necrosis factor functions to maintain spenic architecture and humoral responsiveness in adult mice. Eur. J. Immunol. 27:2033-2042.
64. Maniatis, T. 1997. Catalysis by a multiprotein IκB kinase complex. Science 278:818-819.
65. Matsumoto, M., T.-Y. Hsieh, N. Zhu, T. Vanarsdale, S. B. Hwang, K.-S. Jeng, A. E. Gorbalenya, S.-Y. Lo, J.-H. Ou, C. F. Ware, and M. M. Lai. 1997. Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-β receptor. J. Virol. 71:1301-1309.
66. McKinsey, T. A., J. A. Brockman, D. C. Scherer, S. W. Al-Murrani, P. Green, and D. W. Ballard. 1996. Inactivation of IκBβ by the Tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-κB. Mol. Cell. Biol. 16:2083-2090.
67. Meyer, C. F., X. Wang, C. Chang, D. Templeton, and T.-H. Tan. 1996 Interaction between C-Rel and the mitogen-activated protein kinase kinase kinase 1 signaling cascade in mediating κB enhancer activation. J. Biol. Chem. 271:8971-8976.
68. Minden, A., A. Lin, F.-X. Claret, A. Abo, and M. Karin. 1995. Selective activation of the JNK-signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs. Cell 81:1147-1157.
69. Mosialos, G., M. Birkenbach, R. Yalamanchili, T. VanArsdale, C. F. Ware, and E. Kieff. 1995. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80:389-399.
70. Nagata, S. 1997. Apoptosis by death factor. Cell 88:355-365.
71. Nakano, H., H. Oshima, W. chung, L. Williams-Aboitt, C. F. Ware, H. Yagita, and K. Okumura. 1996. TRAF5, an activator of NF-κB and putative signal transducer for the lymphotoxin-β receptor. J. Biol. Chem. 271:14661-14664.
72. Nakano, H., M. Shindo, S. Sakon, S. Nishinaka, M. Mihara, H. Yagita, and K. Okumura. 1998. Differential regulation of IκB kinase α and β by two upstream kinases. NF-κB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1. Proc. Natl. Acad. Sci. USA 95:3537-3542.
73. Ray, R. B., L. M. Lagging, K. Meyer, R. Steele, and R. Ray. 1995. Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein. Virus Res. 37:209-220.
74. Ray, R. B., L. M. Lagging, K. Meyer, R. Steele, and R. Ray. 1996. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J. Virol. 70:4438-4443.
75. Ray, R. B., K. Meyer, and R. Ray. 1996. Suppression of apoptotic cell death by hepatitis C virus core protein. Virology 226:176-182.
76. Ray, R. B., K. Meyer, A. Shrivastava, B. B. Aggarwaland, and R. Ray. 1998. Inhibition of tumor necrosis factor (TNF-alpha)-mediated apoptosis by hepatitis C virus core protein. J Biol. Chem. 273:2256-2259.
77. Ray, R. B., R. Steele, K. Meyer, and R. Ray. 1997. Transcriptional repression of p53 promoter by hepatitis C virus core protein. J. Biol. Chem. 272:10983-10986.
78. Regnier, C. H., H. Y. Song, X. Gao, D. V. Goeddel, Z. Cao, and M. Rothe. 1997. Identification and characterization of an IκB kinase. Cell 90:373-383.
79. Reinhard, C., B. Shamoon, V. Shyamala, and L. T. Williams. 1997. Tumor necrosis factor α-induced activation of c-Jun N-terminal kinase is mediated by TRAF2. EMBO J. 16:1080-1092
80. Rice, C. M., and C. M. Walker. 1995. Hepatitis C virus-specific T lymphocyte responses. Curr. Opin. Immunol. 7:532-538.
81. Rothe, M., V. Sarrna, V. M. Dixit, and D. V. Goeddel. 1995. TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science 269: 1424-1427.
82. Ruggieri, A., T. Harada, Y. Matsuura, and T. Miyamura. 1997. Fas-mediated apoptosis by hepatitis C virus core protein. Virology 229:68-76.
83. Saito, I., T. Miyamura, A. Ohbayashi, H. Harada, S. Katayama, S. Kikuchi, Y. Watanabe, S. Koi, M. Onji, Q.-L. Choo, M. Houghton, and G. Kuo. 1990. Hepatitis C virus infection is associated with the development of hepato-cellular carcinoma. Proc. Natl. Acad. Sci. USA 87:6547-6549.
84. Sanchez, I., R. T. Hughes, B. J. Mayer, K. Yee, J. R. Woodgett, J. Avruch, J. M. Kyriakis, and L. I. Zon. 1994. Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature 372: 794-798.
85. Sandberg, M., W. Hammerschmidt, and B. Sugden. 1997 Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3. J. Virol. 71: 4649-4656.
86. Santolini, E., G. Migliaccio, and N. L. Monica. 1994. Biosynthesis and biochemical properties of the hepatitis C virus core protein. J. Virol. 68: 3631-3641.
87. Shin, C.-M., C.-M. Cheo, S.-Y. Chen, and Y.-H. W. Lee. 1995. Modulation of the trans-suppression activity of hepatitis C virus core protein by phosphorylation. J. Virol. 69:1160-1171.
88. Shin, C.-M., S. J. Lo, T. Miyamura, S.-Y. Chen, and Y.-H. W. Lee. 1993. Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. J. Virol. 67:5823-5832.
89. Song, H. Y., C. H. Regnier, C. J. Kirschning. D. V. Goeddel, and M. Rothe. 1997. TNF-mediated kinase cascades: bifurcation of NF-κB and JNK/SAPK pathways at TRAF2. Proc. Natl. Acad. Sci. USA 94:9792-9796.
90. Stancovski, I., and D. Baltimore. 1997. NF-κB activation: the IκB kinase revealed? Cell 91:299-302.
91. Su, F., and R. J. Schneider. 1996. Hepatitis B virus HBx protein activates transcription factor NF-κB by acting on multiple cytoplasmic inhibitor of rel-related proteins. J. Virol. 70:4558-4566.
92. Sun, S.-C, J. Elwood, C. Beraud, and W. C. Greene. 1994. Human T-cell leukemia virus type 1 Tax activation of NF-κB/Rel involves phosphorylation and degradation of IκBα and RelA (p65)-mediated induction of the c-rel gene. Mol. Cell. Biol. 14:7377-7384.
93. Sun, S. C., P. A. Ganchi, D. W. Ballard, and W. C. Greene. 1993 NF-κB controls expression of inhibitor IκB-κ: evidence for an inducible autoregulatory pathway. Science 259:1912-1915.
94. Suzuki, T., H. Hirai, J. Fujisawa, T. Fujita, and M. Yoshda. 1993. A trans-activator Tax of human T-cell leukemia virus type 1 binds to NF-kappa B p50 and serum response factor (SRF) and associates with enhancer DNAs of the NF-kappa B site and CArG box. Oncogene 8:2391-2397.
95. Suzuki, T., H. Hirai, T. Murakami, and M. Yoshda. 1995. Tax protein of HTLV-1 destabilizes the complexes of NF-κB and IκB-α and induces nuclear translocation of NF-κB for transcriptional activation. Oncogene 10: 1199-1207.
96. Suzuki, T., H. Hirai, and M. Yoshda. 1994. Tax protein of HTLV-1 interacts with the Rel homology domain of NF-κB p65 and C-Rel protein hound to the NF-κB binding site and activates transcription. Oncogene 9:3099-3105.
97. Tewari, M., and V. M. Dixit. 1996. Recent advances in tumor necrosis factor and CD40 signaling. Curr. Opin. Genet. Dev. 6:39-44.
98. Thanos, D., and T. Maniatis. 1995. NF-κB: a lesson in family values. Cell 80:529-532.
99. Thompson, J. E., R. J. Phillips, H. Erdjument-Bromage, P. Tempst, and S. Ghosh. 1995. IκB-β regulates the persistent response in a biphasic activation of NF-κB Cell 80:573-582.
100. Tomei, L., C. Failla, E. Santolini, R. D. Francesco, and N. L. Monica. 1993 NS3 is a serine protease required for processing of hepatitis C virus polyprotein. J. Virol. 67:4017-4026.
101. Van Antwerp, D. J., S. J. Martin, T. Kafri, D. R. Green, and I. M. Verma. 1996. Suppression of TNF-α-induced apoptosis by NF-κB. Science 274:787-789.
102. VanArsdale, T. L., S. L. VanArsdale, W. Force, B. N. Walker, G. Mosialos, E. Kieff, J. C. Reed, and C. F. Ware. 1997. Lymphotoxin-β receptor signaling complex: role of tumor necrosis factor-associated factor 3 recruitment in cell death and activation of nuclear factor κB. Proc. Natl. Acad. Sci USA 94:2460-2465.
103. Vandenabeele, P., W. Declercq, R. Beyaert, and W. Fiers. 1995. Two tumor necrosis factor receptors: structure and function. Trends Cell Biol, 5:392-399.
104. Verheij. M., R. Bose, X. H. Lin, B. Yao, W. D. Jarvis, S. Grant, M. J. Birrer, E. Szabo, L. I. Zon, J. M. Kyriakis, and R. N. Kolesnick. 1996. Requirement for ceramide-initialed SAPK/JNK signalling in stress-induced apoptosis. Nature 380:75-79.
105. Verma, I. M., and J. Stevenson. 1997. IκB kinase: beginning, not the end. Proc. Natl. Acad. Sci. USA 94:11758-11760.
106. Verma, I. M., J. K. Stevenson, E. M. Schwartz, D. Van Antwerp, and S. Miyamoto. 1995. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev. 9:2723-2735.
107. Wang, C-Y., M. W. Mayo, and A. S. Baldwin. 1996. TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science 274:784-787.
108. Ware, C. F., T. L. VanArsdale, P. D. Crowe, and J. L. Browning. 1995. The ligands and receptors of the lymphotoxin system. Curr. Top. Microhiol. Immunol. 198:175-218.
109. Whitmarsh, A. J., P. Shore, A. D. Sharrocks, and R. J. Davis. 1995. Integration of MAP kinase signal transduction pathways at the serum response element. Science 269:403-407.
110. Xia, Z., M. Dickens, J. Raingeaud, R. J. Davis, and M. E. Greenberg. 1996. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331.
111. Van, M.,T. Dai, J. C. Deak, J. M. Kyriakis, L. I. Zon, J. R. Woodgett, and D. J. Templeton. 1994. Activation of stress-activated protein kinase by MEKK1 phosphorylation of its activator SEK1. Nature 372:798-800.
112. Yin, M.-J., L. B. Christerson, Y. Yamamoto, Y.-T. Kwak, S. Xu, K. Mercurio, M. Barbosa, M. H. Cobb, and R. B. Gaynor. 1998. HTLV-1 Tax protein hinds to MEKK1 to stimulate IκB kinase activity and NF-κB activation. Cell 93:875-884.
113. Zhu, N., A. Khoshnan, R. Schneider, M. Matsumoto, G. Dennert, C. Ware, and M. M. C. Lai. 1998. Hepatitis C virus core protein hinds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoplosis. J. Virol. 72:3691-3697.